drugset / Trial / NCT00894101

Positron Emission Tomography Imaging With [F-18] FLT Compared to [F-18] FDG in Cancer Patients for Treatment Evaluation

NCT00894101

Phase 2/3 Withdrawn University of California, Irvine
Non-randomizedSingle-groupOpen-labelDiagnostic

Summary

The purpose of this study is to investigate the clinical value of serial quantitative \[F-18\] FLT as a PET imaging tool in head and neck cancer patients clinically scheduled with radiation or radiation-chemotherapy combination in terms of safety and efficacy. Standard \[F-18\] FDG PET will be the active comparator.

Timeline

Start
2009-05
Primary completion
2010-04
Completion
2010-04

Drugs

EvaluationDrugModalityDoseRoute
Subject 18F-FLT Diagnostic / imaging agent 370 mbq
Subject FDG Diagnostic / imaging agent 370 mbq

Indications